CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Chirag Patel

President and Co-Chief Executive Officer, Amneal Pharmaceuticals, Inc.

Search every verified Chirag Patel interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Chirag Patel, president and co-CEO of Amneal Pharmaceuticals, announced in October 2024 that the company would invest ₹1,600 crore in two new manufacturing facilities in Ahmedabad, India, to produce GLP-1 drugs for obesity and metabolic diseases. Patel said the investment was part of an effort to bring these drugs to market earlier than typical generics, which he estimated could arrive in 2030–2032, and described the collaboration with biotech startup Metera as a global deal with manufacturing in India for worldwide distribution. He also stated that the U.S. market for these drugs was about $1 billion and could reach $200 billion globally by 2032–2033. In earlier appearances, Patel discussed Amneal’s U.S. business and India strategy. In March 2023, he said U.S. generic price erosion of 10–12 percent was "not sustainable" and that the company was looking to make India a "second home market," citing India's economic growth and rising health awareness. He also commented on the company's quality record, stating Amneal had never faced issues with the U.S. Food and Drug Administration, though he acknowledged a plant had received 15 observations in 2023 that he said were cleared. During 2021 earnings calls, Patel addressed COVID-19 impacts in India, saying the company had secured inventory and did not expect shortages, and discussed the need for more U.S. manufacturing capacity for pharmaceuticals. At a 2019 entrepreneurship conference, he recounted his family's immigrant background and emphasized building long-term relationships and investing in innovation, including a call for India to move beyond generics toward creating intellectual property.

Recent appearances

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →